* OrthoPediatrics Corp KIDS.OQ KIDS.O is expected
to show a
rise in quarterly revenue when it reports results on May 6 for
the period ending March 31 2024
* The Warsaw Indiana Indiana-based company is expected to
report
a 32.2% increase in revenue to $41.775 million from $31.59
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* LSEG's mean analyst estimate for OrthoPediatrics Corp is
for a
loss of 40 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $38.50, above its last closing price of $32.83.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.28 -0.28 -0.29 Missed -3.4
Jan. 1 2023 -0.23 -0.23 -0.20 Beat 10.3
Jun. 30 2023 -0.20 -0.22 -0.13 Beat 39.9
Mar. 31 2023 -0.37 -0.36 -0.30 Beat 17.8
Dec. -0.23 -0.25 -0.35 Missed -38.4
31 2022
Sep. 30 2022 -0.20 -0.20 -0.07 Beat 65.7
Jun. 30 2022 -0.22 -0.21 -0.02 Beat 90.7
Mar. 31 2022 -0.38 -0.37 -0.47 Missed -26.7
This summary was machine generated May 4 at 02:59 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)